C164H202F3N27O7 — CID 167658664
5-cyclopropyl-4-propan-2-yl-1H-indazole;1,6-dimethyl-7-propan-2-ylbenzotriazole;3,6-dimethyl-7-propan-2-yl-2H-indazole;5-methoxy-1-methyl-7-propan-2-ylindazole;6-methoxy-4-propan-2-yl-1H-indazole;6-methyl-1-propan-2-ylindazol-3-amine;6-methyl-1-propan-2-ylindazole;6-methyl-1-propan-2-yl-2H-indazol-3-one;N-(5-methyl-4-propan-2-yl-1H-indazol-3-yl)acetamide;5-methyl-4-propan-2-yl-3-(trifluoromethyl)-2H-indazole;4-propan-2-yl-1H-benzimidazole;8-propan-2-yl-2H-naphthalen-1-one;5-propan-2-yl-3H-quinolin-4-one;8-propan-2-yl-3H-quinolin-4-one (PubChem CID 167658664) has the molecular formula C164H202F3N27O7 and a molecular weight of 2720.60 g/mol. Its IUPAC name is 5-cyclopropyl-4-propan-2-yl-1H-indazole;1,6-dimethyl-7-propan-2-ylbenzotriazole;3,6-dimethyl-7-propan-2-yl-2H-indazole;5-methoxy-1-methyl-7-propan-2-ylindazole;6-methoxy-4-propan-2-yl-1H-indazole;6-methyl-1-propan-2-ylindazol-3-amine;6-methyl-1-propan-2-ylindazole;6-methyl-1-propan-2-yl-2H-indazol-3-one;N-(5-methyl-4-propan-2-yl-1H-indazol-3-yl)acetamide;5-methyl-4-propan-2-yl-3-(trifluoromethyl)-2H-indazole;4-propan-2-yl-1H-benzimidazole;8-propan-2-yl-2H-naphthalen-1-one;5-propan-2-yl-3H-quinolin-4-one;8-propan-2-yl-3H-quinolin-4-one.
| Compound Name | 5-cyclopropyl-4-propan-2-yl-1H-indazole;1,6-dimethyl-7-propan-2-ylbenzotriazole;3,6-dimethyl-7-propan-2-yl-2H-indazole;5-methoxy-1-methyl-7-propan-2-ylindazole;6-methoxy-4-propan-2-yl-1H-indazole;6-methyl-1-propan-2-ylindazol-3-amine;6-methyl-1-propan-2-ylindazole;6-methyl-1-propan-2-yl-2H-indazol-3-one;N-(5-methyl-4-propan-2-yl-1H-indazol-3-yl)acetamide;5-methyl-4-propan-2-yl-3-(trifluoromethyl)-2H-indazole;4-propan-2-yl-1H-benzimidazole;8-propan-2-yl-2H-naphthalen-1-one;5-propan-2-yl-3H-quinolin-4-one;8-propan-2-yl-3H-quinolin-4-one |
|---|---|
| PubChem CID | 167658664 |
| Molecular Formula | C164H202F3N27O7 |
| Molecular Weight | 2720.60 g/mol |
| Exact Mass | 2718.62 |
| IUPAC Name | 5-cyclopropyl-4-propan-2-yl-1H-indazole;1,6-dimethyl-7-propan-2-ylbenzotriazole;3,6-dimethyl-7-propan-2-yl-2H-indazole;5-methoxy-1-methyl-7-propan-2-ylindazole;6-methoxy-4-propan-2-yl-1H-indazole;6-methyl-1-propan-2-ylindazol-3-amine;6-methyl-1-propan-2-ylindazole;6-methyl-1-propan-2-yl-2H-indazol-3-one;N-(5-methyl-4-propan-2-yl-1H-indazol-3-yl)acetamide;5-methyl-4-propan-2-yl-3-(trifluoromethyl)-2H-indazole;4-propan-2-yl-1H-benzimidazole;8-propan-2-yl-2H-naphthalen-1-one;5-propan-2-yl-3H-quinolin-4-one;8-propan-2-yl-3H-quinolin-4-one |
| SMILES | CC(=O)Nc1n[nH]c2ccc(C)c(C(C)C)c12.CC(C)c1c(C2CC2)ccc2[nH]ncc12.CC(C)c1cccc2[nH]cnc12.CC(C)c1cccc2c1C(=O)CC=C2.CC(C)c1cccc2c1C(=O)CC=N2.CC(C)c1cccc2c1N=CCC2=O.COc1cc(C(C)C)c2c(cnn2C)c1.COc1cc(C(C)C)c2cn[nH]c2c1.Cc1ccc2c(=O)[nH]n(C(C)C)c2c1.Cc1ccc2c(C)[nH]nc2c1C(C)C.Cc1ccc2c(N)nn(C(C)C)c2c1.Cc1ccc2cnn(C(C)C)c2c1.Cc1ccc2n[nH]c(C(F)(F)F)c2c1C(C)C.Cc1ccc2nnn(C)c2c1C(C)C |
| InChI | InChI=1S/C13H17N3O.C13H16N2.C13H14O.C12H13F3N2.C12H16N2O.C12H16N2.2C12H13NO.2C11H15N3.2C11H14N2O.C11H14N2.C10H12N2/c1-7(2)11-8(3)5-6-10-12(11)13(16-15-10)14-9(4)17;1-8(2)13-10(9-3-4-9)5-6-12-11(13)7-14-15-12;1-9(2)11-7-3-5-10-6-4-8-12(14)13(10)11;1-6(2)9-7(3)4-5-8-10(9)11(17-16-8)12(13,14)15;1-8(2)11-6-10(15-4)5-9-7-13-14(3)12(9)11;1-7(2)11-8(3)5-6-10-9(4)13-14-12(10)11;1-8(2)9-4-3-5-10-12(9)11(14)6-7-13-10;1-8(2)9-4-3-5-10-11(14)6-7-13-12(9)10;1-7(2)10-8(3)5-6-9-11(10)14(4)13-12-9;1-7(2)14-10-6-8(3)4-5-9(10)11(12)13-14;1-7(2)9-4-8(14-3)5-11-10(9)6-12-13-11;1-7(2)13-10-6-8(3)4-5-9(10)11(14)12-13;1-8(2)13-11-6-9(3)4-5-10(11)7-12-13;1-7(2)8-4-3-5-9-10(8)12-6-11-9/h5-7H,1-4H3,(H2,14,15,16,17);5-9H,3-4H2,1-2H3,(H,14,15);3-7,9H,8H2,1-2H3;4-6H,1-3H3,(H,16,17);5-8H,1-4H3;5-7H,1-4H3,(H,13,14);2*3-5,7-8H,6H2,1-2H3;5-7H,1-4H3;4-7H,1-3H3,(H2,12,13);4-7H,1-3H3,(H,12,13);4-7H,1-3H3,(H,12,14);4-8H,1-3H3;3-7H,1-2H3,(H,11,12) |
| InChIKey | RQDAVSDUSNZZMR-UHFFFAOYSA-N |
| XLogP | 41.58 |
| TPSA | 443.55 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 18 |
| Heavy Atoms | 201 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2720.60 |
| LogP ≤ 5 | 41.58 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 26 |